Publication | Closed Access
A novel rabies vaccine based-on toll-like receptor 3 (TLR3) agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies
38
Citations
14
References
2016
Year
VaccinationCross-protectionVaccine DevelopmentNovel RabiesVaccine TargetAnimal StudiesImmunologyExcellent SafetyVaccine DesignPolyvalent VaccineMedicineVaccine Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1